Better look (and think) twice—TNF-alpha-inhibition and multiple sclerosis

The tumor necrosis factor alpha (TNF-alpha) inhibitor etanercept has been approved for the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriasis and psoriatic arthritis (PA). MS is a serious, chronic, and often debilitating disease. [...]the decision whether to prescribe TNF...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical neurology and neurosurgery 2013-07, Vol.115 (7), p.1195-1196
1. Verfasser:	Scheid, Rainer, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Arthritis, Juvenile - complications Arthritis, Juvenile - drug therapy Biologicals Demyelinating Diseases - chemically induced Demyelinating Diseases - pathology Etanercept Female Humans Immunoglobulin G - adverse effects Immunoglobulin G - therapeutic use Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Magnetic Resonance Imaging MRI Multiple sclerosis Multiple Sclerosis - chemically induced Neurology Neurosurgery Receptors, Tumor Necrosis Factor - therapeutic use TNF inhibitors TNF-alpha-inhibitors Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The tumor necrosis factor alpha (TNF-alpha) inhibitor etanercept has been approved for the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriasis and psoriatic arthritis (PA). MS is a serious, chronic, and often debilitating disease. [...]the decision whether to prescribe TNF-alpha inhibitors should be well thought out.
ISSN:	0303-8467 1872-6968
DOI:	10.1016/j.clineuro.2012.09.012